Plasma exchange for thrombotic microangiopathy secondary to dermatomyositis associated with acute kidney injury and complement activation: A case report with literature review

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Thrombotic microangiopathy (TMA) in patients with connective tissue disease is rare but life-Threatening. In particular, the survival rate of patients with dermatomyositis (DM) that develop TMA is low. The effectiveness of plasma exchange (PEX) therapy is unclear for the treatment of TMA secondary to DM. Case presentation: We describe a case of a 28-year-old woman who developed severe DM complicated by aspiration pneumonia from dysphagia and acute kidney injury. The patient was unresponsive to corticosteroids and intravenous immunoglobulin (IVIG) therapy and developed TMA. In this case, immunofluorescence of skin biopsy revealed that complement activation was involved in the pathogenesis of DM. After 6 PEX therapies, thrombocytopenia improved. She was successfully treated by intensive care and PEX therapy. Conclusions: PEX therapy was effective to treat TMA secondary to DM associated with complement activation.

Cite

CITATION STYLE

APA

Hayashi, N., Okada, K., Tsuruyama, Y., Kagaya, Y., Kumano, S., Ishikura, Y., … Yokoyama, H. (2019, December 5). Plasma exchange for thrombotic microangiopathy secondary to dermatomyositis associated with acute kidney injury and complement activation: A case report with literature review. Renal Replacement Therapy. BioMed Central Ltd. https://doi.org/10.1186/s41100-019-0244-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free